 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Cancer immunotherapy .net |
|
|
|
Information on human tumours 1 |
|
|
|
 |
|
 |
|
|
|
|
 |
|
|
|
|
|
cancerimmunotherapy@yahoo.com |
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
tumour type |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
news |
|
|
|
|
|
|
 |
|
|
|
|
Pulmonary metastases of renal cancer |
|
|
|
|
|
|
|
|
|
|
Data in short:
Five-year survival: 0% without local IL-2 21% with local IL-2
Local IL-2 is new standard treatment |
|
|
|
1994 |
|
|
|
|
|
1997 |
|
|
|
|
|
|
|
2003 |
|
|
|
|
|
|
|
Huland and Heinzer, 2003 |
|
|
|
2004 |
|
|
|
|
|
|
|
|
|
|
|
Huland and Heinzer, 2004 |
|
|
|
|
|
|
|
Huland et al., 2004 |
|
|
|
 |
|
|
|
tumour type |
|
 |
|
|
|
|
|
|
|
|
Interleukin-2 (IL-2) Mechanism of IL-2 therapy of cancer Cancers sensitve to IL-2 Surgery and IL-2 Radiotherapy and IL-2 Chemotherapy and IL-2 Experts I want to co-operate (doctors) Frequently Asked Questions (FAQs) |
|
|
|
 |
|
|
|
|
|
cancerimmunotherapy@yahoo.com |
|
|
|
|
|
Information for doctors Information for patients I want to support this research or more information on the EPTI fund supporting this research |
|
|
|
Stichting ter bevordering van het onderzoek in de Experimentele Pathologie en in het bijzonder in de TumourImmunologie. Stichting EPTI, IJselstein, The Netherlands |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|